Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | LAP3 | P28838 | 4/20 | 0.47 |
| ▸ | ANPEP | P15144 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2845167 | 1.00 | EPHX1 (0.54) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL9625571 | 1.00 | EPHX1 (0.54) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL9627376 | 1.00 | EPHX1 (0.54) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL9819869 | 1.00 | EPHX1 (0.54) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6445044 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6356479 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL6929688 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL7190709 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL22431194 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA | |
| SCHEMBL9740410 | 0.82 | EPHX1 (0.58) | EPHX1SLC15A1SLC6A2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100366605-C | Compounds to treat alzheimer's disease | ELAN PHARM INC (US) | 2008-02-06 | — | — | CN | claimed |
| CN-1447789-A | Compounds for treating alzheimer's disease | ELAN PHARM INC (US) | 2003-10-08 | — | — | CN | claimed |
| EP-0296059-B1 | TRIPEPTIDES WITH A POLYCYCLIC NITROGEN STRUSTURE, THEIR PROCESS OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THEREOF | ADIR ET COMPAGNIE (FR) | 1992-03-18 | — | — | EP | claimed |
| CN-101878210-B | Amide compounds as boosters of antivirals | TIBOTEC PHARM LTD | 2013-07-17 | — | — | CN | disclosed |
| CN-101868457-B | (3-hydroxy-4-amino-but-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for use in therapy | COMENTIS INC | 2013-02-13 | — | — | CN | disclosed |
| EP-2477992-A2 | PROCESSES FOR THE PREPARATION OF DARUNAVIR AND THE AMORPHOUS FORM THEREOF | MYLAN LABORATORIES LIMITED (IN) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011048604-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF DARUNAVIR | MATRIX LABORATORIES LIMITED (IN) | 2011-04-28 | — | — | WO | disclosed |
| CN-101878210-A | Amide compound as boosters | TIBOTEC PHARM LTD | 2010-11-03 | — | — | CN | disclosed |
| CN-101868457-A | (3-hydroxy-4-amino-but-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for use in therapy | COMENTIS INC | 2010-10-20 | — | — | CN | disclosed |
| CN-101821238-A | Suppress the active isophthaloyl sulfonamide derivatives of beta-secretase (BETA-SECRETASE) | COMENTIS INC | 2010-09-01 | — | — | CN | disclosed |
| EP-1222192-B8 | HEXAHYDROFURO¬2,3-B FURAN-3-YL-N- 3-¬(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO -1-BENZYL-2-HYDROXYPROPYL CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR | TIBOTEC PHARM LTD (IE) | 2008-10-01 | — | — | EP | disclosed |
| CN-1090612-C | Amine derivatives of oxo-and hydroxy-substituted hydrocarbons | NARHEX LTD (HK) | 2002-09-11 | — | — | CN | disclosed |
| EP-1222192-A1 | HEXAHYDROFURO[2,3-B]FURAN-3-YL-N- 3-[(1,3-BENZODIOXOL-5-YLSULFONYL)(ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYL CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR | Tibotec Pharmaceuticals Ltd. (IE) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001025240-A1 | HEXAHYDROFURO'2,3-B!FURAN-3-YL-N- {3'(1,3-BENZODIOXOL -5- YLSULFONYL) (ISOBUTYL) AMINO! -1-BENZYL-2-HYDROXYPROPYL} CARBAMATE AS RETROVIRAL PROTEASE INHIBITOR | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2001-04-12 | — | — | WO | disclosed |
| US-5776933-A | Method of inhibiting protease | E. R. SQUIBB & SONS, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5760036-A | ENZYME INHIBITORS OF RETROVIRAL PROTEASE FOR PREVENTION OF AIDS | E. R. SQUIBB & SONS, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| CN-1100090-A | amine derivatives of oxo-and hydroxy-substituted hydrocarbons | NARHEX LTD (HK) | 1995-03-15 | — | — | CN | disclosed |
| CN-1085546-A | Aminediol protease inhibitors | SQUIBB & SONS INC (US) | 1994-04-20 | — | — | CN | disclosed |